Amesite Amends 10-K, Details Leadership & Governance

Ticker: AMST · Form: 10-K/A · Filed: 2025-10-28T00:00:00.000Z

Sentiment: bearish

Topics: 10-K/A, Corporate Governance, Executive Leadership, Risk Factors, Financial Reporting, Small Cap, AI Education

Related Tickers: AMST

TL;DR

**Amesite's 10-K/A finally pulls back the curtain on its leadership, but the core risks of profitability and funding remain a huge red flag for this micro-cap.**

AI Summary

Amesite Inc. filed a 10-K/A on October 28, 2025, to amend and restate Part III, Items 10 through 14 of its Annual Report for the fiscal year ended June 30, 2025. This amendment primarily provides detailed information on Directors, Executive Officers, Corporate Governance, Executive Compensation, Security Ownership, Related Transactions, and Principal Accountant Fees, which were previously omitted. The company's market value of common stock held by non-affiliates was approximately $15,375,000 as of December 31, 2024, with a closing price of $4.75 per share on the Nasdaq Capital Market. As of October 24, 2025, there were 4,572,713 shares of common stock outstanding. Dr. Ann Marie Sastry, 58, continues to serve as CEO, President, and Chairman, a role she has held since November 2017. Sarah Berman, 40, was appointed Principal Financial and Accounting Officer on December 15, 2024, succeeding Sherlyn W. Farrell, 63, who served as CFO from December 2022 to December 2024. The filing highlights the company's reliance on its 'Site' (products and services including NurseMagic.ai) and lists key risks such as achieving profitability, obtaining additional funds, and maintaining intellectual property protection.

Why It Matters

This 10-K/A provides crucial transparency for investors by detailing Amesite's executive leadership, board composition, and corporate governance structure, information previously omitted. Understanding who is at the helm, including Dr. Ann Marie Sastry's continued leadership and the new Principal Financial and Accounting Officer, Sarah Berman, is vital for assessing strategic direction and financial oversight. The competitive landscape in AI-driven education and healthcare platforms, like NurseMagic.ai, demands strong governance, and this filing clarifies the individuals responsible for navigating market challenges and executing growth strategies. For employees and customers, stable and transparent leadership signals reliability and long-term vision.

Risk Assessment

Risk Level: high — The filing explicitly lists 'our ability to continue as a going concern' and 'our ability to obtain additional funds for our operations' as key risks, indicating significant financial uncertainty. Furthermore, the company's market capitalization of approximately $15,375,000 as of December 31, 2024, and its status as a smaller reporting company, suggest limited financial resources and heightened vulnerability to market fluctuations and operational challenges.

Analyst Insight

Investors should exercise extreme caution and conduct thorough due diligence on Amesite Inc. given the explicit 'going concern' risk and the need for additional funding. Monitor future filings for concrete plans to address these financial vulnerabilities and for any significant changes in revenue or net income that could indicate a path to profitability.

Executive Compensation

NameTitleTotal Compensation
Ann Marie Sastry, Ph.D.Chief Executive Officer, President, Chairman of Board of Directors
Sarah BermanPrincipal Financial and Accounting Officer
Sherlyn W. FarrellFormer Chief Financial Officer

Key Numbers

Key Players & Entities

FAQ

What is the purpose of Amesite Inc.'s 10-K/A filing?

The 10-K/A filing by Amesite Inc. is an amendment to its Annual Report on Form 10-K for the fiscal year ended June 30, 2025. Its primary purpose is to amend and restate Part III, Items 10 through 14, which include information on Directors, Executive Officers, Corporate Governance, Executive Compensation, Security Ownership, Related Transactions, and Principal Accountant Fees, previously omitted in reliance on General Instruction G(3).

Who are the key executive officers and directors of Amesite Inc. as of October 28, 2025?

As of October 28, 2025, key executive officers and directors of Amesite Inc. include Dr. Ann Marie Sastry (58), Chief Executive Officer, President, and Chairman; Sarah Berman (40), Principal Financial and Accounting Officer; and directors Barbie Brewer (49), J. Michael Losh (79), Gilbert S. Omenn, M.D., Ph.D. (84), and George Parmer (86). Sherlyn W. Farrell (63) is noted as the former Chief Financial Officer.

What was Amesite Inc.'s market value of common stock held by non-affiliates?

The aggregate market value of Amesite Inc.'s common stock held by non-affiliates was approximately $15,375,000 as of December 31, 2024. This valuation was based on a closing price of $4.75 per share for the common stock on the Nasdaq Capital Market on that date.

What are the primary risks highlighted in Amesite Inc.'s 10-K/A filing?

The primary risks highlighted in Amesite Inc.'s 10-K/A filing include the company's ability to continue as a going concern, its ability to obtain additional funds for operations, and its ability to deliver solutions that offer meaningful return on investment (ROI) to customers. Other risks involve maintaining intellectual property protection and reliance on third parties.

How many shares of Amesite Inc. common stock were outstanding on October 24, 2025?

On October 24, 2025, there were 4,572,713 shares of common stock of Amesite Inc., with a par value of $0.0001 per share, issued and outstanding.

What is Dr. Ann Marie Sastry's background before Amesite Inc.?

Before founding Amesite Inc. in November 2017, Dr. Ann Marie Sastry served as President, CEO, and co-founder of Sakti3 from April 2008 to October 2015, which was sold to Dyson Ltd. for $90 million in 2015. She then led Dyson's global solid-state battery team until November 2017 and was previously an Arthur F. Thurnau Professor of engineering at the University of Michigan for 17 years.

When did Sarah Berman become Principal Financial and Accounting Officer for Amesite Inc.?

Sarah Berman assumed the role of Principal Financial and Accounting Officer for Amesite Inc. on December 15, 2024. She succeeded Sherlyn W. Farrell, who served as Chief Financial Officer from December 2022 to December 2024.

What is NurseMagic.ai and its relation to Amesite Inc.?

NurseMagic.ai is a product owned and operated by Amesite Inc. It is part of Amesite's 'Site,' which collectively refers to all of the company's products and services, including software, hardware, content, technology, and advanced analytics, available via its website and mobile app.

Why did Amesite Inc. choose to include Part III information by amendment rather than incorporation by reference?

Amesite Inc. determined to include the Part III information by amendment of the Original Form 10-K rather than incorporation by reference to a proxy statement. This decision was made to ensure the information, previously omitted in reliance on General Instruction G(3) to Form 10-K, is directly presented within the amended annual report.

What is the board leadership structure at Amesite Inc.?

Amesite Inc. maintains a combined board leadership structure where Dr. Ann Marie Sastry serves as both Chief Executive Officer, President, and Chairman of the board of directors. The company believes this structure is effective as it leverages Dr. Sastry's deep knowledge and leadership as the founder to efficiently lead the board and company.

Risk Factors

Industry Context

Amesite Inc. operates in the online learning and artificial intelligence education technology sector. This industry is characterized by rapid innovation, increasing demand for personalized learning solutions, and a competitive landscape with both established players and emerging startups. Key trends include the integration of AI for adaptive learning, the growth of micro-credentialing, and the need for scalable platforms to serve diverse educational and corporate training needs.

Regulatory Implications

As a publicly traded company, Amesite Inc. is subject to SEC regulations and disclosure requirements. The filing of a 10-K/A highlights the importance of accurate and timely reporting. Failure to comply with these regulations, or any misstatements in filings, could lead to investigations, fines, and reputational damage.

What Investors Should Do

  1. Review the detailed disclosures in Part III (Items 10-14) of the 10-K/A to understand executive compensation structures, board composition, and related-party transactions, as these were previously omitted.
  2. Assess the company's stated risks, particularly concerning profitability and funding, in light of its current operational stage and market position.
  3. Monitor future filings for updates on revenue generation, profitability trends, and the company's ability to secure necessary funding, which are critical for its long-term viability.

Key Dates

Glossary

10-K/A
An amended annual report filed with the SEC. The '/A' indicates it's an amendment to a previously filed report. (This filing is an amendment to Amesite's annual report, providing updated or additional information.)
Part III, Items 10 through 14
These sections of a 10-K report typically cover Directors, Executive Officers and Corporate Governance; Executive Compensation; Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters; and Certain Relationships and Related Transactions, and Director Independence. (The amendment specifically addresses these critical governance and disclosure items, which are important for investor understanding of the company's leadership and internal dealings.)
Non-affiliates
Individuals or entities that are not officers, directors, or major shareholders of a company, and do not have a controlling interest. (The market value of stock held by non-affiliates is a key metric for assessing the public float and market capitalization available to general investors.)
Principal Financial and Accounting Officer
The officer responsible for the company's financial reporting and accounting practices. This role is often held by the CFO or a senior accounting executive. (The appointment of Sarah Berman to this role is a significant change in financial management and oversight.)

Year-Over-Year Comparison

This 10-K/A filing is an amendment to the previous annual report, specifically addressing Part III, Items 10-14, which were initially omitted. Therefore, a direct comparison of key financial metrics like revenue growth or margin changes to a prior period within this specific amendment is not possible. The primary change is the addition of detailed information regarding corporate governance, executive compensation, and security ownership, providing a more complete picture of the company's structure and leadership than previously available.

Filing Stats: 4,523 words · 18 min read · ~15 pages · Grade level 12.2 · Accepted 2025-10-28 16:20:53

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES 20 i PART III

Directors, Executive Officers and Corporate Governance

Item 10. Directors, Executive Officers and Corporate Governance Executive Officers and Directors Set forth below is certain information with respect to the individuals who are our directors and executive officers as of October 28, 2025: Name Age Positions Ann Marie Sastry, Ph.D. 58 Chief Executive Officer, President, Chairman of Board of Directors Sarah Berman 40 Principal Financial and Accounting Officer Sherlyn W. Farrell 63 Former Chief Financial Officer Barbie Brewer 49 Director J. Michael Losh 79 Director Gilbert S. Omenn, M.D., Ph.D. 84 Director George Parmer 86 Director Ann Marie Sastry, Ph.D. - Chief Executive Officer, President, Chairman of Board of Directors Dr. Sastry has served as our Chief Executive Officer, President and Chairman of the board of directors since our incorporation in November 2017. From April 2008 to October 2015, Dr. Sastry served as the President, Chief Executive Officer, member of the board of directors and co-founder of Sakti3, recognized as one of the Massachusetts Institute of Technology's 50 Smartest Companies in 2015. Backed by a global team of venture capitalists Sakti3 was sold to Dyson Ltd. in 2015 for $90 million. Dr. Sastry was invited to the White House in 2015 to be recognized for her technology entrepreneurship and to meet with President Barack Obama. From October 2015 to November 2017, Dr. Sastry continued on with Dyson as head of the global solid state battery team, focusing on technology strategy and advancement, staff and organizational growth, and partnership development. Her technology and business work have been featured in the Wall Street Journal, Fortune, Forbes, the Economist, USA Today, the New York Times and on the cover of Inc. Prior to starting her companies, Dr. Sastry was a professor of engineering at the University of Michigan (UM). Dr. Sastry was named an Arthur F. Thurnau Professor (UM's highest teaching honor) in 2008. Tenured and promoted early, S

View on Read The Filing